Forum Navigation
You need to log in to create posts and topics.
Endospan’s FDA nod for Nexus brings acquisition by Artivion closer
#1 · April 10, 2026, 8:21 pm
Endospan Ltd. Secured U.S. premarket approval for its Nexus aortic arch stent graft, bringing the company closer to being acquired by Artivion Inc. Under the terms of an existing agreement, Artivion has an option to acquire Endospan at any time within 90 days of the FDA approval.